In different NAFLD-HCC mouse models, removing CD8+ T cells caused opposite effects on HCC progression (Shalapour et al., 2017; Pfister et al., 2021; Wolf et al., 2014). The gene discussed is CD8A; the disease is hepatocellular carcinoma.